Biobanking Market Future Trends and Industry insight to 2022

The biobanking market is expected to reach USD 2.69 billion by 2022 from USD 1.85 billion in 2017, at a CAGR of 7.8%. Factors driving the growth of this market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research, and the growing need for cost-effective drug discovery and development.

Click Here for Complete Report on Biobanking Market spread across 171 Pages, Profiling 13 Companies and Supported with 123 Tables and 38 Figures at http://www.rnrmarketresearch.com/biobanking-market-by-product-and-serviceequipment-consumables-services-software-sample-type-blood-products-human-tissues-cell-lines-nucleic-acids-application-regenerative-medicine-life-science-clinica-st-to-2022-market-report.html .

The biobanking market is classified by storage type into manual and automated storage. The automated storage type segment is expected to grow at a higher rate during the forecast period. This is attributed to launch of new and advanced automated storage equipment and increasing demand for the quality storage of samples.

Introduction

1 Objectives of the Study

2 Market Definition

3 Market Scope

4 Years Considered for the Study

5 Currency

6 Limitations

7 Stakeholders

The biobanking market is segmented based on applications regenerative medicine, life science research, and clinical research. In 2017, the regenerative medicine segment is expected to command the largest share and is also estimated to grow at the fastest rate as compared to other segments. This can be attributed to increasing research activities in the field of regenerative medicine and rising demand for well-annotated and quality bio samples for research.

Click Here for Sample Papers of Biobanking Market with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1158504 .

Geographically, the biobanking market is dominated by North America, followed by Europe. The Asia-Pacific region is estimated to grow at the fastest rate which can be attributed to the large population in China and India, increasing research in regenerative medicine, and improving life sciences research infrastructure in the region.

Global Biobanking Market, By Sample Type

1 Introduction

2 Blood Products

3 Human Tissues

4 Cell Lines

5 Nucleic Acids

6 Biological Fluids

7 Human Waste Products

The report analyses the biobanking market by product and service, sample type, storage type, application and regions. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market.

Click Now for More Details on “Biobanking Market by Product and Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical Research) – Global Forecast to 2022” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1158504 .

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

Contact:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.